About Uromitexan Mesna Infusion 200 mg
Uromitexan Mesna Infusion 200 mg is a distinguished pharmaceutical solution, highly recommended for safeguarding patients during chemotherapy treatments. Trending among medical professionals in India and abroad, this infusion features the extraordinary salt composition Uromitexan, acclaimed for its protective qualities. Designed for injection and offering a shelf life of 12 months, it ensures optimal effectiveness when stored in a cool, dry place. As a trusted exporter and supplier from India, we proudly deliver this champion product for hospitals and clinics seeking personalised treatment solutions.
Versatile Uses and Targeted Application
Uromitexan Mesna Infusion 200 mg stands out for its specific use in protecting the urinary tract from chemotherapy-induced toxicity. It is suitable for both adult and pediatric patients undergoing cancer treatment, making it invaluable in oncological and hematological settings. Highly recommended for use in hospitals and specialized cancer care units, this product's area of application covers a broad spectrum of patient needs, ensuring enhanced safety during intensive chemotherapy sessions.
Streamlined Export Market and Delivery Logistics
Our main export markets for Uromitexan Mesna Infusion 200 mg span Asia, Africa, and the Middle East. We estimate flexible delivery times depending on regional logistics and customer requirements. The product is handed over at a nominated FOB port in India, ensuring timely shipment and safe transit. Export logistics are closely managed by skilled professionals, facilitating seamless handovers and supporting the global reach of this champion infusion product.
FAQ's of Uromitexan Mesna Infusion 200 mg:
Q: How should Uromitexan Mesna Infusion 200 mg be stored for maximum efficacy?
A: It is recommended to store Uromitexan Mesna Infusion 200 mg in a cool and dry place to maintain its potency throughout the 12-month shelf life.
Q: What is the primary benefit of using Uromitexan Mesna Infusion during chemotherapy?
A: This infusion helps protect the urinary tract from the toxic effects of certain chemotherapy agents, reducing the risk of complications associated with cancer treatment.
Q: When is the optimal time to administer Uromitexan Mesna Infusion?
A: Uromitexan Mesna should be given according to the chemotherapy schedule, typically just prior to or simultaneously with the administration of the relevant anticancer agents.
Q: Where is Uromitexan Mesna Infusion 200 mg primarily exported?
A: The primary export destinations are countries across Asia, Africa, and the Middle East, fulfilling demands in hospitals and medical facilities.
Q: What is the usual process for international handover and delivery?
A: Once an order is confirmed, the product is handed over at a designated FOB port in India, after which logistics partners ensure secure and efficient delivery to the destination.